Tredje Ap Fonden Jazz Pharmaceuticals PLC Transaction History

Tredje Ap Fonden

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$114.26 - $136.0 $125,114 - $148,920	-1,095 Reduced 10.34%	9,496 $1.17 Million
Q3 2023 Nov 09, 2023	SELL	$122.0 - $145.31 $121,146 - $144,292	-993 Reduced 8.57%	10,591 $1.37 Million
Q2 2023 Aug 11, 2023	SELL	$122.5 - $147.16 $216,580 - $260,178	-1,768 Reduced 13.24%	11,584 $1.44 Million
Q1 2023 May 10, 2023	BUY	$133.98 - $160.47 $91,240 - $109,280	681 Added 5.37%	13,352 $1.95 Million
Q4 2022 Feb 10, 2023	BUY	$129.72 - $159.85 $48,385 - $59,624	373 Added 3.03%	12,671 $2.02 Million
Q3 2022 Nov 10, 2022	BUY	$126.59 - $161.18 $1.56 Million - $1.98 Million	12,298 New	12,298 $1.64 Million
Q2 2018 Aug 09, 2018	SELL	$146.33 - $183.18 $1.46 Million - $1.83 Million	-9,980 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$135.59 - $157.16 $488,124 - $565,776	3,600 Added 56.43%	9,980 $1.51 Million
Q4 2017 Feb 12, 2018	BUY	$131.06 - $150.39 $424,634 - $487,263	3,240 Added 103.18%	6,380 $859,000
Q3 2017 Nov 13, 2017	BUY	$142.62 - $155.6 $447,826 - $488,584	3,140	3,140 $459,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

Stay updated on Tredje Ap Fonden with notifications on news.